Skip to content

Pregabalin and Colonic Function

Effect of Pregabalin on Colonic Sensorimotor Function in Healthy Adults.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01094808
Enrollment
62
Registered
2010-03-29
Start date
2010-03-31
Completion date
2011-02-28
Last updated
2012-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

pregabalin, motor, sensation, colon, pain, gas

Brief summary

This study is being done to evaluate the effects of pregabalin, a drug approved for anticonvulsive therapy and for neuropathic pain, on colonic and sensory functions in healthy individuals. The specific study hypotheses were as follows: 1) pregabalin increases sensation thresholds, decreases sensation ratings, and increases compliance in response to balloon distension in the colon; 2) pregabalin reduces colonic phasic and tonic motility in response to a standardized meal; and 3) sensation ratings are lower with higher colonic compliance.

Detailed description

The treatment of patients with irritable bowel syndrome and chronic abdominal pain is advancing with several effective options for symptoms related to bowel dysfunction and bloating/distension. However, there are no approved or effective centrally or peripherally acting visceral analgesics. Pregabalin has been proposed as a treatment for visceral pain, based on the pharmacological actions, and efficacy in neuropathic pain. This was a trial of healthy adults to compare the effects of oral pregabalin, 75 mg and 200 mg versus placebo on sensation and contraction of the colon using validated methods. All participants presented on the study day after an overnight bowel preparation with an oral colonic lavage solution and a 12-hour fast. Flexible colonoscopy to the splenic flexure was performed without sedation by one investigator. The barostat catheter (constructed at Mayo Clinic, Rochester, MN) incorporating six manometric point sensors 5 cm apart was introduced into the colon over a guidewire, and the polyethylene balloon (10 cm long, cylindrical shape with a maximum volume of 600 ml) was placed in the mid-descending or junction of the sigmoid and descending colon. A rigid-piston barostat was used to measure intraballoon pressure and volume throughout the study. After an initial inflation to a volume of 75 ml to ensure unfolding of the balloon, the operating pressure was identified as the distension pressure at which respiratory excursions were recorded clearly from the barostat tracing, and the intraballoon pressure was set 2 mm Hg above the minimal distension pressure. A conditioning distention from 0 to 36 mm Hg in increments of 4 mm Hg every 15 seconds was performed over a period of 3 minutes. After an equilibration period of 10 minutes, colonic compliance was assessed by the ascending methods of limit (ramp-like increases of 4 mm Hg at 30 section intervals). During the assessment of colonic compliance, participants reported their thresholds for first perception, gas and pain. After another 10 minute equilibration period, fasting colonic tone was measured at operating pressure for a period of 10 minutes. Randomized-order phasic distentions were then applied at 16, 24, 30, and 36 mm Hg above the operating pressure to measure the sensations of gas and pain. Each distention lasted 1 minute and was followed by an equilibration period at the operating pressure for 2 minutes. A 100-mm visual analog scale (VAS) was used to assess the rating of arousal and stress experienced by each participant before performing the phasic distentions. During the distentions, participants also used the 100-mm VAS to rate the intensity of gas and pain perception at 30 seconds from the start of the distention. Colonic compliance, fasting tone, pressure thresholds for first perception, gas, and pain, and VAS scores of gas and pain during the phasic distentions were measured before administering the study medication and 1 hour after drug administration. After the postdrug assessment of sensation with phasic distentions, a 30-min assessment of fasting colonic tone was measured in each participant; this provided a baseline to compare the effect of a standard 750-ml chocolate milkshake meal across treatment groups. Postprandial tone was measured over 60 minutes, with the main focus on the first 30 minutes. When the recording was completed, the balloon was deflated and the tube removed by gentle traction.

Interventions

DRUGPregabalin

FDA approved medication (capsules) at 75 mg and 200 mg doses

DRUGPlacebo

Placebo capsules

OTHERBowel preparation

Polyethylene glycol electrolyte solution bowel preparation

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
National Center for Research Resources (NCRR)
CollaboratorNIH
Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

\- Healthy males or females

Exclusion criteria

* Abdominal surgery other than appendectomy, laparoscopic cholecystectomy, cesarean section, vaginal or laparoscopic hysterectomy or tubal ligation * A history of chronic gastrointestinal or systemic illnesses that could affect gastrointestinal motility * Any history of hypertension * Use of medications that may alter gastrointestinal motility or interact with the study medications * Use of any of the study medications within the past 30 days * Pregnancy * Chronic renal insufficiency (serum creatinine \>1.5 mg/dL) * Psychiatric or psychologic dysfunction.

Design outcomes

Primary

MeasureTime frameDescription
Postprandial Motility Index Over 30 Minutes30 minutes after the mealThe first 30 minute postprandial motility index (MI), MI = log\_e \[(number of contractions \* sum of amplitudes)+1\]
Sensory Threshold for Painapproximately 60 minutes after drug administrationThe sensory threshold for first perception of pain was measured by stepwise inflation of the balloon in increments of 4 mm Hg at 60 second intervals. The balloon was placed in the mid-descending or junction of the sigmoid and descending colon. During this assessment participants were asked to report when they had the first perception of pain. The investigator recorded the threshold pressure at which the participants reported this sensation.
Sensation Ratings for Pain and Gas at 30 mm Hg Distension Above Baseline Operating PressureApproximately 60 minutes after drug administrationThe 30 mm Hg distension refers to inflation of the balloon placed in placed in the mid-descending or junction of the sigmoid and descending colon. Pain and gas were individually measured by a 100 mm long Visual Analog Scale (VAS). The VAS does not have any pre-set marks between the extremes. For the pain VAS, 0 means no pain and 100 mm means extreme pain. For the gas VAS, 0 means no gas sensation and 100 mm means extreme gas sensation. The investigator measures the mark made by the participant in mm and records this for the value of either pain or gas.
Colonic ComplianceApproximately 60 minutes after drug administrationColonic compliance is a measure of the stiffness of the colon, that is, what pressure was needed to reach half the maximum value of the colon. After the barostat balloon catheter was inserted in the mid-descending or junction of the sigmoid and descending colon, the balloon was inflated. After an initial conditioning distension to 20 mm Hg, colonic compliance was measured by step-wise inflation with increments of 4 mm Hg. Colonic compliance was analyzed by a validated linear interpolation method. The pressure at half maximum volume serves as a summary of colonic compliance.
Postprandial Colonic Tone [Reported] as the Symmetric Percent [Change]in Baseline Colonic Barostat Balloon VolumeThe first 30 minutes postprandially, and preprandial (30 minutes)The symmetric percent reduction in baseline colonic barostat balloon volume during the first 30 minutes postprandially (PP) corrected for the preprandial (30 min) tone, (symmetric percent change= 100\*log\_e\[fasting/PP\]). A positive symmetric percent change reflects a decrease in barostat balloon volume indicating a reduction in colonic tone. (The balloon was placed in the mid-descending or junction of the sigmoid and descending colon.)

Secondary

MeasureTime frameDescription
Sensory Threshold for GasApproximately 60 minutes after drug administrationThe sensory threshold for first perception of gas was measured by stepwise inflation of the balloon in increments of 4 mm Hg at 60 second intervals. (The balloon was placed in the mid-descending or junction of the sigmoid and descending colon.) During this assessment participants were asked to report when they had the first perception of gas. The investigator recorded the threshold pressure at which the participants reported this sensation.
Sensation Ratings for Pain at 16, 24, and 36 mm Hg DistensionApproximately 60 minutes after drug administrationThe mm Hg distensions refer to the barostat balloon, which was placed in the mid-descending or junction of the sigmoid and descending colon. Pain sensation was measured by a 100 mm long Visual Analog Scale (VAS). The VAS does not have any pre-set marks between the extremes. For the pain VAS, 0 means no pain and 100 mm means extreme pain. The investigator measures the mark made by the participant in mm and records this for the value of pain.
Sensation Ratings for Gas at 16, 24, and 36 mm Hg DistensionApproximately 60 minutes after drug administrationThe mm Hg distensions refer to the barostat balloon, which was placed in the mid-descending or junction of the sigmoid and descending colon. Gas sensation was measured by a 100 mm long Visual Analog Scale (VAS). The VAS does not have any pre-set marks between the extremes. For the gas VAS, 0 means no gas sensation and 100 mm means extreme gas sensation. The investigator measures the mark made by the participant in mm and records this for the value of either pain or gas.
Gas Sensation Rating Averaged Across 4 Distension Pressures (16, 24, 30, and 36 mg Hg)Approximately 60 minutes after drug administrationThe mm Hg distensions refer to the barostat balloon, which was placed in the mid-descending or junction of the sigmoid and descending colon. Gas sensation was measured by a 100 mm long Visual Analog Scale (VAS). The VAS does not have any pre-set marks between the extremes. For the gas VAS, 0 means no gas sensation and 100 mm means extreme gas sensation. The investigator measures the mark made by the participant in mm and records this for the value of gas. The values across the 4 distension pressures were averaged for this outcome measure.
Pain Sensation Rating Averaged Across 4 Distension Pressures (16, 24, 30, and 36 mg Hg)Approximately 60 minutes after drug administrationThe mm Hg distensions refer to the barostat balloon, which was placed in the mid-descending or junction of the sigmoid and descending colon. Pain sensation was measured by a 100 mm long Visual Analog Scale (VAS). The VAS does not have any pre-set marks between the extremes. For the pain VAS, 0 means no pain and 100 mm means extreme pain. The investigator measures the mark made by the participant in mm and records this for the value of pain. The values across the 4 distension pressures were averaged for this outcome measure.

Countries

United States

Participant flow

Recruitment details

The study was conducted between April 2010 and January 2011 at the Mayo Clinic, Rochester, Minnesota.

Participants by arm

ArmCount
Pregabalin 75 mg
Subjects randomized to this arm received a single dose of pregabalin 75 mg orally
21
Pregabalin 200 mg
Subjects randomized to this arm received a single dose of pregabalin 200 mg orally
20
Placebo
Subjects randomized to this arm received a single dose of placebo medication orally
21
Total62

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyWithdrawal by Subject110

Baseline characteristics

CharacteristicPregabalin 75 mgPregabalin 200 mgPlaceboTotal
Age Continuous32.2 years
STANDARD_DEVIATION 11.9
32.4 years
STANDARD_DEVIATION 9.1
31.6 years
STANDARD_DEVIATION 11.8
32 years
STANDARD_DEVIATION 11
Body Mass Index (BMI)25.8 kg/m^2
STANDARD_DEVIATION 3.7
26.7 kg/m^2
STANDARD_DEVIATION 6.3
26.4 kg/m^2
STANDARD_DEVIATION 4.4
26.3 kg/m^2
STANDARD_DEVIATION 0.6
Region of Enrollment
United States
21 participants20 participants21 participants62 participants
Sex: Female, Male
Female
16 Participants15 Participants15 Participants46 Participants
Sex: Female, Male
Male
5 Participants5 Participants6 Participants16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
14 / 2019 / 199 / 21
serious
Total, serious adverse events
0 / 200 / 190 / 21

Outcome results

Primary

Colonic Compliance

Colonic compliance is a measure of the stiffness of the colon, that is, what pressure was needed to reach half the maximum value of the colon. After the barostat balloon catheter was inserted in the mid-descending or junction of the sigmoid and descending colon, the balloon was inflated. After an initial conditioning distension to 20 mm Hg, colonic compliance was measured by step-wise inflation with increments of 4 mm Hg. Colonic compliance was analyzed by a validated linear interpolation method. The pressure at half maximum volume serves as a summary of colonic compliance.

Time frame: Approximately 60 minutes after drug administration

ArmMeasureValue (MEAN)Dispersion
Pregabalin 75 mgColonic Compliance17.6 mm HgStandard Deviation 5.1
Pregabalin 200 mgColonic Compliance19.1 mm HgStandard Deviation 4.6
PlaceboColonic Compliance17.4 mm HgStandard Deviation 4.8
Primary

Postprandial Colonic Tone [Reported] as the Symmetric Percent [Change]in Baseline Colonic Barostat Balloon Volume

The symmetric percent reduction in baseline colonic barostat balloon volume during the first 30 minutes postprandially (PP) corrected for the preprandial (30 min) tone, (symmetric percent change= 100\*log\_e\[fasting/PP\]). A positive symmetric percent change reflects a decrease in barostat balloon volume indicating a reduction in colonic tone. (The balloon was placed in the mid-descending or junction of the sigmoid and descending colon.)

Time frame: The first 30 minutes postprandially, and preprandial (30 minutes)

ArmMeasureValue (MEAN)Dispersion
Pregabalin 75 mgPostprandial Colonic Tone [Reported] as the Symmetric Percent [Change]in Baseline Colonic Barostat Balloon Volume21.9 Symmetric percentage changeStandard Deviation 12.4
Pregabalin 200 mgPostprandial Colonic Tone [Reported] as the Symmetric Percent [Change]in Baseline Colonic Barostat Balloon Volume35.3 Symmetric percentage changeStandard Deviation 25.2
PlaceboPostprandial Colonic Tone [Reported] as the Symmetric Percent [Change]in Baseline Colonic Barostat Balloon Volume27.8 Symmetric percentage changeStandard Deviation 21.8
Primary

Postprandial Motility Index Over 30 Minutes

The first 30 minute postprandial motility index (MI), MI = log\_e \[(number of contractions \* sum of amplitudes)+1\]

Time frame: 30 minutes after the meal

ArmMeasureGroupValue (MEAN)Dispersion
Pregabalin 75 mgPostprandial Motility Index Over 30 MinutesMotility index distal colon at 30 minutes8.806 log mm HgStandard Deviation 3.095
Pregabalin 75 mgPostprandial Motility Index Over 30 MinutesMotility index proximal colon at 30 minutes11.264 log mm HgStandard Deviation 1.609
Pregabalin 200 mgPostprandial Motility Index Over 30 MinutesMotility index distal colon at 30 minutes9.783 log mm HgStandard Deviation 2.849
Pregabalin 200 mgPostprandial Motility Index Over 30 MinutesMotility index proximal colon at 30 minutes11.764 log mm HgStandard Deviation 1.357
PlaceboPostprandial Motility Index Over 30 MinutesMotility index proximal colon at 30 minutes11.465 log mm HgStandard Deviation 1.339
PlaceboPostprandial Motility Index Over 30 MinutesMotility index distal colon at 30 minutes9.879 log mm HgStandard Deviation 2.235
Primary

Sensation Ratings for Pain and Gas at 30 mm Hg Distension Above Baseline Operating Pressure

The 30 mm Hg distension refers to inflation of the balloon placed in placed in the mid-descending or junction of the sigmoid and descending colon. Pain and gas were individually measured by a 100 mm long Visual Analog Scale (VAS). The VAS does not have any pre-set marks between the extremes. For the pain VAS, 0 means no pain and 100 mm means extreme pain. For the gas VAS, 0 means no gas sensation and 100 mm means extreme gas sensation. The investigator measures the mark made by the participant in mm and records this for the value of either pain or gas.

Time frame: Approximately 60 minutes after drug administration

ArmMeasureGroupValue (MEAN)Dispersion
Pregabalin 75 mgSensation Ratings for Pain and Gas at 30 mm Hg Distension Above Baseline Operating PressureSensation ratings for pain at 30 mm Hg47.4 mmStandard Deviation 28.3
Pregabalin 75 mgSensation Ratings for Pain and Gas at 30 mm Hg Distension Above Baseline Operating PressureSensation ratings for gas at 30 mm Hg53.4 mmStandard Deviation 27.9
Pregabalin 200 mgSensation Ratings for Pain and Gas at 30 mm Hg Distension Above Baseline Operating PressureSensation ratings for pain at 30 mm Hg36.1 mmStandard Deviation 28.4
Pregabalin 200 mgSensation Ratings for Pain and Gas at 30 mm Hg Distension Above Baseline Operating PressureSensation ratings for gas at 30 mm Hg33.2 mmStandard Deviation 19.6
PlaceboSensation Ratings for Pain and Gas at 30 mm Hg Distension Above Baseline Operating PressureSensation ratings for gas at 30 mm Hg46.6 mmStandard Deviation 22.3
PlaceboSensation Ratings for Pain and Gas at 30 mm Hg Distension Above Baseline Operating PressureSensation ratings for pain at 30 mm Hg46.0 mmStandard Deviation 28.7
Primary

Sensory Threshold for Pain

The sensory threshold for first perception of pain was measured by stepwise inflation of the balloon in increments of 4 mm Hg at 60 second intervals. The balloon was placed in the mid-descending or junction of the sigmoid and descending colon. During this assessment participants were asked to report when they had the first perception of pain. The investigator recorded the threshold pressure at which the participants reported this sensation.

Time frame: approximately 60 minutes after drug administration

ArmMeasureValue (MEAN)Dispersion
Pregabalin 75 mgSensory Threshold for Pain45.8 mm HgStandard Deviation 14.9
Pregabalin 200 mgSensory Threshold for Pain46.7 mm HgStandard Deviation 13.9
PlaceboSensory Threshold for Pain45.0 mm HgStandard Deviation 14
Secondary

Gas Sensation Rating Averaged Across 4 Distension Pressures (16, 24, 30, and 36 mg Hg)

The mm Hg distensions refer to the barostat balloon, which was placed in the mid-descending or junction of the sigmoid and descending colon. Gas sensation was measured by a 100 mm long Visual Analog Scale (VAS). The VAS does not have any pre-set marks between the extremes. For the gas VAS, 0 means no gas sensation and 100 mm means extreme gas sensation. The investigator measures the mark made by the participant in mm and records this for the value of gas. The values across the 4 distension pressures were averaged for this outcome measure.

Time frame: Approximately 60 minutes after drug administration

ArmMeasureValue (MEAN)Dispersion
Pregabalin 75 mgGas Sensation Rating Averaged Across 4 Distension Pressures (16, 24, 30, and 36 mg Hg)43.379 mmStandard Deviation 23.413
Pregabalin 200 mgGas Sensation Rating Averaged Across 4 Distension Pressures (16, 24, 30, and 36 mg Hg)33.391 mmStandard Deviation 22.106
PlaceboGas Sensation Rating Averaged Across 4 Distension Pressures (16, 24, 30, and 36 mg Hg)41.789 mmStandard Deviation 22.278
Comparison: ANCOVA for overall treatment effectsp-value: 0.14ANCOVA
Secondary

Pain Sensation Rating Averaged Across 4 Distension Pressures (16, 24, 30, and 36 mg Hg)

The mm Hg distensions refer to the barostat balloon, which was placed in the mid-descending or junction of the sigmoid and descending colon. Pain sensation was measured by a 100 mm long Visual Analog Scale (VAS). The VAS does not have any pre-set marks between the extremes. For the pain VAS, 0 means no pain and 100 mm means extreme pain. The investigator measures the mark made by the participant in mm and records this for the value of pain. The values across the 4 distension pressures were averaged for this outcome measure.

Time frame: Approximately 60 minutes after drug administration

ArmMeasureValue (MEAN)Dispersion
Pregabalin 75 mgPain Sensation Rating Averaged Across 4 Distension Pressures (16, 24, 30, and 36 mg Hg)44.364 mmStandard Deviation 23.478
Pregabalin 200 mgPain Sensation Rating Averaged Across 4 Distension Pressures (16, 24, 30, and 36 mg Hg)35.301 mmStandard Deviation 22.295
PlaceboPain Sensation Rating Averaged Across 4 Distension Pressures (16, 24, 30, and 36 mg Hg)43.286 mmStandard Deviation 23.678
Comparison: ANCOVA for overall treatment effectsp-value: 0.12ANCOVA
Secondary

Sensation Ratings for Gas at 16, 24, and 36 mm Hg Distension

The mm Hg distensions refer to the barostat balloon, which was placed in the mid-descending or junction of the sigmoid and descending colon. Gas sensation was measured by a 100 mm long Visual Analog Scale (VAS). The VAS does not have any pre-set marks between the extremes. For the gas VAS, 0 means no gas sensation and 100 mm means extreme gas sensation. The investigator measures the mark made by the participant in mm and records this for the value of either pain or gas.

Time frame: Approximately 60 minutes after drug administration

ArmMeasureGroupValue (MEAN)Dispersion
Pregabalin 75 mgSensation Ratings for Gas at 16, 24, and 36 mm Hg DistensionSensation Ratings for Gas at 36 mm Hg distention49.65 mmStandard Deviation 25.06
Pregabalin 75 mgSensation Ratings for Gas at 16, 24, and 36 mm Hg DistensionSensation Ratings for Gas at 16 mm Hg distention37.40 mmStandard Deviation 25.1
Pregabalin 75 mgSensation Ratings for Gas at 16, 24, and 36 mm Hg DistensionSensation Ratings for Gas at 24 mm Hg distention44.05 mmStandard Deviation 26.51
Pregabalin 200 mgSensation Ratings for Gas at 16, 24, and 36 mm Hg DistensionSensation Ratings for Gas at 36 mm Hg distention36.58 mmStandard Deviation 22.42
Pregabalin 200 mgSensation Ratings for Gas at 16, 24, and 36 mm Hg DistensionSensation Ratings for Gas at 16 mm Hg distention30.00 mmStandard Deviation 25.25
Pregabalin 200 mgSensation Ratings for Gas at 16, 24, and 36 mm Hg DistensionSensation Ratings for Gas at 24 mm Hg distention32.00 mmStandard Deviation 21.83
PlaceboSensation Ratings for Gas at 16, 24, and 36 mm Hg DistensionSensation Ratings for Gas at 36 mm Hg distention46.24 mmStandard Deviation 22.36
PlaceboSensation Ratings for Gas at 16, 24, and 36 mm Hg DistensionSensation Ratings for Gas at 16 mm Hg distention37.14 mmStandard Deviation 22.62
PlaceboSensation Ratings for Gas at 16, 24, and 36 mm Hg DistensionSensation Ratings for Gas at 24 mm Hg distention42.76 mmStandard Deviation 23.87
Secondary

Sensation Ratings for Pain at 16, 24, and 36 mm Hg Distension

The mm Hg distensions refer to the barostat balloon, which was placed in the mid-descending or junction of the sigmoid and descending colon. Pain sensation was measured by a 100 mm long Visual Analog Scale (VAS). The VAS does not have any pre-set marks between the extremes. For the pain VAS, 0 means no pain and 100 mm means extreme pain. The investigator measures the mark made by the participant in mm and records this for the value of pain.

Time frame: Approximately 60 minutes after drug administration

ArmMeasureGroupValue (MEAN)Dispersion
Pregabalin 75 mgSensation Ratings for Pain at 16, 24, and 36 mm Hg DistensionSensation ratings of pain at 16 mm distension28.70 mmStandard Deviation 24.27
Pregabalin 75 mgSensation Ratings for Pain at 16, 24, and 36 mm Hg DistensionSensation ratings of pain at 36 mm distension44.30 mmStandard Deviation 23.96
Pregabalin 75 mgSensation Ratings for Pain at 16, 24, and 36 mm Hg DistensionSensation ratings of pain at 24 mm distension43.00 mmStandard Deviation 30.66
Pregabalin 200 mgSensation Ratings for Pain at 16, 24, and 36 mm Hg DistensionSensation ratings of pain at 24 mm distension36.84 mmStandard Deviation 28.55
Pregabalin 200 mgSensation Ratings for Pain at 16, 24, and 36 mm Hg DistensionSensation ratings of pain at 16 mm distension29.00 mmStandard Deviation 28.47
Pregabalin 200 mgSensation Ratings for Pain at 16, 24, and 36 mm Hg DistensionSensation ratings of pain at 36 mm distension43.37 mmStandard Deviation 26.94
PlaceboSensation Ratings for Pain at 16, 24, and 36 mm Hg DistensionSensation ratings of pain at 16 mm distension34.29 mmStandard Deviation 28.24
PlaceboSensation Ratings for Pain at 16, 24, and 36 mm Hg DistensionSensation ratings of pain at 36 mm distension47.62 mmStandard Deviation 30.45
PlaceboSensation Ratings for Pain at 16, 24, and 36 mm Hg DistensionSensation ratings of pain at 24 mm distension39.48 mmStandard Deviation 29.78
Secondary

Sensory Threshold for Gas

The sensory threshold for first perception of gas was measured by stepwise inflation of the balloon in increments of 4 mm Hg at 60 second intervals. (The balloon was placed in the mid-descending or junction of the sigmoid and descending colon.) During this assessment participants were asked to report when they had the first perception of gas. The investigator recorded the threshold pressure at which the participants reported this sensation.

Time frame: Approximately 60 minutes after drug administration

ArmMeasureValue (MEAN)Dispersion
Pregabalin 75 mgSensory Threshold for Gas27.6 mm HgStandard Deviation 18.3
Pregabalin 200 mgSensory Threshold for Gas34.3 mm HgStandard Deviation 11.1
PlaceboSensory Threshold for Gas34.5 mm HgStandard Deviation 16.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026